ReviewFrontiers in medical technology2026
Gold nanoparticles in skin drug delivery: a bibliometric analysis of research trends from 2015 to 2025.
Review in Frontiers in medical technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gold nanoparticles (AuNPs) have emerged as highly effective nanocarriers for skin drug delivery due to their tunable physicochemical properties, large surface area, and ease of functionalization. Over the past decade, research in this field has expanded rapidly, driven by advances in nanotechnology and increasing interest in non-invasive topical and transdermal-based therapies. In this study, a comprehensive bibliometric analysis was conducted to evaluate global research trends in gold nanoparticle-based skin drug delivery between January 1, 2015, to December 31, 2025. using the Web of Science and Scopus databases. Publications were identified through structured keyword-based searches focused on "gold nanoparticles" and "skin drug delivery", and analyzed for publication output, leading contributors, research areas, and keyword co-occurrence using VOSviewer. The results reveal a significant growth in publications, particularly after 2020, with major contributions from Asia, especially India and China. Key research themes include wound healing, antibacterial applications, and skin cancer treatment, with an increasing emphasis on nanocarrier design and controlled drug-delivery systems. This study provides a systematic overview of the research landscape, offering insights into emerging trends and influential contributors. However, it is limited by database selection, potential keyword bias, and the descriptive nature of bibliometric analysis, which does not include experimental validation. Despite these limitations, the findings contribute to a clearer understanding of the development and future direction of gold nanoparticle-based skin drug delivery research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.